Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China (NM-in-RCIP)

July 1, 2021 updated by: Qingyuan Zhan, China-Japan Friendship Hospital
The important role of nutritional management in the treatment of ICU patients has been paid more and more attention. Reasonable nutritional management can improve the nutritional status of patients, reduce the risk of malnutrition, shorten the length of ICU stay, improve the quality of life of patients, and reduce the mortality of patients, thereby improving the prognosis. Many studies have investigated the nutritional status and implementation of ICU patients. It is generally believed that the nutritional status of ICU patients is not good, and the implementation of standardization needs to be improved.The data on the nutritional status and implementation of RICU patients in mainland China is rare. Therefore, the main purpose of this study is to investigate the implementation and compliance of nutritional support treatment for RICU patients in mainland China.

Study Overview

Status

Recruiting

Detailed Description

Respiratory critically ill patients have their own disease metabolism and treatment methods. However, RICU medical staff generally do not pay enough attention to nutrition support treatment. The data on the nutritional status and implementation of RICU patients in China is rare. But the data plays an important role in carrying out nutrition-related research, formulating the goals of continuing education programs for nutrition support treatment, guiding the introduction of medical insurance policies and the revision of consensus. Therefore, the main purpose of this study is to investigate the implementation and compliance of nutritional support treatment for RICU patients in tertiary hospitals in mainland China, so as to lay the foundation for further relevant work.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100028
        • Recruiting
        • China-Japan Friendship Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The patients admitted to RICU

Description

Inclusion Criteria:

  • patients aged >18 years
  • the length of RICU stays >48 hours

Exclusion Criteria:

  • patients aged ≤18 years
  • the length of RICU stays ≤48 hours
  • patients who were admitted to RICU due to or combined with severe trauma or surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of enteral nutrition starting within 48 hours after ICU entry
Time Frame: 48 hours
Proportion of enteral nutrition starting within 48 hours after ICU entry
48 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutritional status and risk of malnutrition on ICU admission
Time Frame: 48 hours
To assess nutritional status and risk of malnutrition on ICU admission by NRS-2002 risk score and NUTRIC score
48 hours
The proportion of subjects receiving>80% estimated energy target within 7 days after ICU entry
Time Frame: 7 days
The proportion of subjects receiving>80% estimated energy target within 7 days after ICU entry
7 days
The proportion of enteral nutrition intolerance
Time Frame: 48 hours
The proportion of enteral nutrition intolerance
48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

July 1, 2021

Primary Completion (ANTICIPATED)

July 1, 2021

Study Completion (ANTICIPATED)

August 12, 2021

Study Registration Dates

First Submitted

March 28, 2021

First Submitted That Met QC Criteria

July 1, 2021

First Posted (ACTUAL)

July 12, 2021

Study Record Updates

Last Update Posted (ACTUAL)

July 12, 2021

Last Update Submitted That Met QC Criteria

July 1, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nutritional Deficiency

3
Subscribe